Endovascular Treatment for Femoropopliteal Arterial Lesions with a Focus on Long-Term Limb Prognosis.

Abstract

Femoropopliteal (FP) arterial lesions represent the most prevalent and challenging targets for endovascular therapy (EVT) in patients with lower extremity artery disease (LEAD). Despite significant advances in device technology, FP interventions continue to be limited by high rates of restenosis and occlusion. To date, no conclusive evidence has demonstrated the superiority of any specific endovascular device strategy for FP artery disease. Importantly, stent restenosis is characterized by longer lesion lengths and a higher incidence of occlusive failure, which may substantially compromise the feasibility of subsequent reintervention.